Market closedNon-fractional

ProPhase Labs/PRPH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ProPhase Labs

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Ticker

PRPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Garden City, United States

Employees

113

ProPhase Labs Metrics

BasicAdvanced
$62M
Market cap
-
P/E ratio
-$0.67
EPS
-0.17
Beta
-
Dividend rate
$62M
-0.17
1.884
1.52
40.471
52.016
-19.55%
-20.76%
-45.03%
4.02
1.31
2.1
-5.625
-69.59%
-459.33%
0.97%
301.35%

What the Analysts think about ProPhase Labs

Analyst Ratings

Majority rating from 1 analysts.
Buy

ProPhase Labs Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-172.22% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.6M
5.88%
Net income
-$6.2M
-28.74%
Profit margin
-172.22%
-32.70%

ProPhase Labs Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 75.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.20
-$0.30
-$0.51
-$0.07
-
Expected
-$0.14
-$0.20
-$0.26
-$0.28
-$0.25
Surprise
42.86%
53.85%
96.15%
-75.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ProPhase Labs stock?

ProPhase Labs (PRPH) has a market cap of $62M as of July 06, 2024.

What is the P/E ratio for ProPhase Labs stock?

The price to earnings (P/E) ratio for ProPhase Labs (PRPH) stock is 0 as of July 06, 2024.

Does ProPhase Labs stock pay dividends?

No, ProPhase Labs (PRPH) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next ProPhase Labs dividend payment date?

ProPhase Labs (PRPH) stock does not pay dividends to its shareholders.

What is the beta indicator for ProPhase Labs?

ProPhase Labs (PRPH) has a beta rating of -0.17. This means that it has an inverse relation to market volatility.

Buy or sell ProPhase Labs stock

Buy or sell ProPhase Labs stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing